Gene correction for a rare disease

July 2, 2014
Gene correction for a rare disease

Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.

Until now there has been no effective treatment, but a new gene therapy developed within the EU-funded project AIPgene could provide patients an end to their ordeal and reactivate the production of the missing protein. The new gene therapy consists of a single injection of a viral vector containing the healthy gene. Such gene will then replace the mutated one in . This treatment is expected to stop the symptoms of the disease for five to ten years, depending on the life cycle of the cells in the liver.

During the phase I of a clinical trial Angeles and seven other patients have received this treatment, and so far AIP attacks have been reduced significantly among this group. In addition, there are no side effects visible. These promising results indicate that within a few years, the new therapy could be available to all patients.

The video will load shortly

Explore further: Predicting hepatitis C treatment success

Related Stories

Predicting hepatitis C treatment success

May 8, 2014

Levels of interferon-stimulated genes in the liver and blood could help predict if a patient with hepatitis C will respond to conventional therapy, researchers at Kanazawa University suggest.

Targeted gene therapy enhances treatment for Pompe disease

June 25, 2012

Gene therapy to replace the protein missing in Pompe disease can be effective if the patient's immune system does not react against the therapy. Targeted delivery of the gene to the liver, instead of throughout the body,suppresses ...

Recommended for you

UK experts give green light to 'three-parent babies'

November 30, 2016

British scientists on Wednesday approved the use of so-called "three-parent baby" fertility treatments, paving the way for the country to become the first in the world to officially introduce the procedures.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.